| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2006PNAS..10312469G |
| P356 | DOI | 10.1073/PNAS.0603029103 |
| P932 | PMC publication ID | 1567903 |
| P698 | PubMed publication ID | 16891421 |
| P5875 | ResearchGate publication ID | 6896330 |
| P50 | author | Joseph Buxbaum | Q15428933 |
| Nick Craddock | Q18685542 | ||
| Vahram Haroutunian | Q47157894 | ||
| Valentina Escott-Price | Q56528787 | ||
| Lesley Jones | Q56855569 | ||
| Nicholas Bray | Q57419559 | ||
| Nadine Norton | Q96190598 | ||
| George Kirov | Q30004103 | ||
| Michael C O'Donovan | Q30410265 | ||
| Peter Holmans | Q37649643 | ||
| Stanley Zammit | Q37651777 | ||
| Dobril Ivanov | Q42683162 | ||
| Stuart Macgregor | Q42711014 | ||
| P2093 | author name string | Nigel Williams | |
| Michael J Owen | |||
| Ivan Nikolov | |||
| Lyudmila Georgieva | |||
| Hywel Williams | |||
| Jennifer Wilkinson | |||
| Kenneth L Davis | |||
| Tim Peirce | |||
| P2860 | cites work | Inference of population structure using multilocus genotype data | Q24548114 |
| Failure of spinal cord oligodendrocyte development in mice lacking neuregulin | Q24554441 | ||
| Neuregulin 1 and susceptibility to schizophrenia | Q24616921 | ||
| The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia | Q24798030 | ||
| Haploview: analysis and visualization of LD and haplotype maps | Q27860955 | ||
| Schizophrenia: genes at last? | Q28260969 | ||
| Olig transcription factors are expressed in oligodendrocyte and neuronal cells in human fetal CNS | Q28280124 | ||
| DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling | Q28282412 | ||
| Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia | Q47820010 | ||
| The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages. | Q48546876 | ||
| Olig2 overexpression induces the in vitro differentiation of neural stem cells into mature oligodendrocytes | Q48715127 | ||
| Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients | Q48738469 | ||
| Electron microscopy of oligodendroglia in severe mental illness. | Q48772850 | ||
| Differential rates of psychiatric disorders in adults with Down's syndrome compared with other mentally handicapped adults. | Q50305372 | ||
| Interstitial deletion of chromosome 21q and schizophrenia susceptibility. | Q50766897 | ||
| Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. | Q51943076 | ||
| Pedigree disequilibrium tests for multilocus haplotypes. | Q52010978 | ||
| The ErbB4 neuregulin receptor mediates suppression of oligodendrocyte maturation. | Q52047054 | ||
| Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. | Q53654455 | ||
| Olig2 directs astrocyte and oligodendrocyte formation in postnatal subventricular zone cells. | Q53662277 | ||
| Universal, robust, highly quantitative SNP allele frequency measurement in DNA pools. | Q53668847 | ||
| Convergent Evidence for 2′,3′-Cyclic Nucleotide 3′-Phosphodiesterase as a Possible Susceptibility Gene for Schizophrenia | Q57279160 | ||
| Design of Case-controls Studies with Unscreened Controls | Q58132458 | ||
| Evaluation of Nyholt’s Procedure for Multiple Testing Correction – Author’s Reply | Q59590791 | ||
| Sonic hedgehog--regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system | Q73555176 | ||
| Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis | Q78077743 | ||
| Microarray analysis of postmortem temporal cortex from patients with schizophrenia | Q80502608 | ||
| Evaluation of Nyholt's procedure for multiple testing correction | Q81105171 | ||
| Expression pattern of the transcription factor Olig2 in response to brain injuries: implications for neuronal repair | Q28285265 | ||
| The involvement of ErbB4 with schizophrenia: association and expression studies | Q28290653 | ||
| Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors | Q28592141 | ||
| Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection | Q28594759 | ||
| affy--analysis of Affymetrix GeneChip data at the probe level | Q29547353 | ||
| Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. | Q30819593 | ||
| Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert | Q30869659 | ||
| Regional and cellular gene expression changes in human Huntington's disease brain | Q33233457 | ||
| A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other | Q33909759 | ||
| Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia | Q33941953 | ||
| Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans | Q34152058 | ||
| Oligodendrocyte dysfunction in schizophrenia and bipolar disorder | Q34246905 | ||
| Prefrontal abnormality of schizophrenia revealed by DNA microarray: impact on glial and neurotrophic gene expression | Q34367536 | ||
| The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons | Q34498146 | ||
| An 'oligarchy' rules neural development | Q34750265 | ||
| Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia | Q35014711 | ||
| White matter changes in schizophrenia: evidence for myelin-related dysfunction | Q35125866 | ||
| DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. | Q38325560 | ||
| Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study | Q38519890 | ||
| Mind glue: implications of glial cell biology for psychiatry | Q40782511 | ||
| Process outgrowth in oligodendrocytes is mediated by CNP, a novel microtubule assembly myelin protein | Q41888821 | ||
| Combinatorial profiles of oligodendrocyte-selective classes of transcriptional regulators differentially modulate myelin basic protein gene expression. | Q42810403 | ||
| No association between schizophrenia and polymorphisms in COMT in two large samples | Q46681218 | ||
| P433 | issue | 33 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oligodendrocyte | Q916698 |
| schizophrenia | Q41112 | ||
| P304 | page(s) | 12469-74 | |
| P577 | publication date | 2006-08-15 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia | |
| P478 | volume | 103 |
| Q26770756 | A New Outlook on Mental Illnesses: Glial Involvement Beyond the Glue |
| Q49629866 | A Novel Ultrasensitive In Situ Hybridization Approach to Detect Short Sequences and Splice Variants with Cellular Resolution |
| Q35014891 | A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depression |
| Q33785737 | A systematic enhancer screen using lentivector transgenesis identifies conserved and non-conserved functional elements at the Olig1 and Olig2 locus |
| Q35832061 | AKT/GSK3 signaling pathway and schizophrenia |
| Q81038294 | Adaptive evolution of genes underlying schizophrenia |
| Q26773159 | Advancements in the Underlying Pathogenesis of Schizophrenia: Implications of DNA Methylation in Glial Cells |
| Q28250481 | An association screen of myelin-related genes implicates the chromosome 22q11 PIK4CA gene in schizophrenia |
| Q42698412 | An examination of single nucleotide polymorphism selection prioritization strategies for tests of gene-gene interaction |
| Q48953087 | Association of white matter deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized VBM study using 3T. |
| Q37002050 | Basic helix-loop-helix transcription factor NEUROG1 and schizophrenia: effects on illness susceptibility, MRI brain morphometry and cognitive abilities |
| Q27313562 | Bovine exome sequence analysis and targeted SNP genotyping of recessive fertility defects BH1, HH2, and HH3 reveal a putative causative mutation in SMC2 for HH3 |
| Q40437176 | Currently recognized genes for schizophrenia: High-resolution chromosome ideogram representation. |
| Q34531769 | Disturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules |
| Q51893653 | Effect of a functional single nucleotide polymorphism in the 2',3'-cyclic nucleotide 3'-phosphodiesterase gene on the expression of oligodendrocyte-related genes in schizophrenia. |
| Q36491749 | Essential role of B-Raf in oligodendrocyte maturation and myelination during postnatal central nervous system development |
| Q36484847 | Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia |
| Q59812978 | Genetic and Epigenetic Alterations Underlie Oligodendroglia Susceptibility and White Matter Etiology in Psychiatric Disorders |
| Q35153945 | Genetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brains |
| Q34603780 | Genetic underpinnings of white matter 'connectivity': heritability, risk, and heterogeneity in schizophrenia |
| Q91938001 | Genomics of the OLIG family of a bHLH transcription factor associated with oligo dendrogenesis |
| Q38373219 | Glia-related genes and their contribution to schizophrenia |
| Q91194418 | Glial cells in schizophrenia: a unified hypothesis |
| Q37546096 | Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy |
| Q38665790 | Human iPSC Glial Mouse Chimeras Reveal Glial Contributions to Schizophrenia |
| Q33516442 | Imaging genetics of structural brain connectivity and neural integrity markers |
| Q50803888 | Integrated genetic and genomic approach in the SingaporeTranslational and Clinical Research in Psychosis Study: an overview. |
| Q38091301 | Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders |
| Q37800531 | Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia |
| Q37564007 | Linking white and grey matter in schizophrenia: oligodendrocyte and neuron pathology in the prefrontal cortex |
| Q35808940 | Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders |
| Q34639446 | Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene |
| Q36672435 | Morphine effects on striatal transcriptome in mice |
| Q34680959 | Myelin, copper, and the cuprizone model of schizophrenia |
| Q36591201 | Myelination-related genes are associated with decreased white matter integrity in schizophrenia |
| Q37076200 | Neuregulin 1 genotype and schizophrenia |
| Q31111596 | Neuroimaging studies of children with serious emotional disturbances: a selective review |
| Q41430196 | Neurotoxocarosis alters myelin protein gene transcription and expression |
| Q95270886 | Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia |
| Q89747364 | Novel genetic susceptibility loci identified by family based whole exome sequencing in Han Chinese schizophrenia patients |
| Q37517222 | Oligodendrocyte development and the onset of myelination in the human fetal brain |
| Q24289198 | Oligodendrocyte genes, white matter tract integrity, and cognition in schizophrenia |
| Q64062621 | Oligodendrocytes: Potential of Discovering New Treatment Targets |
| Q28221773 | PADB: published association database |
| Q81437003 | Positive association between OLIG2 and schizophrenia in the Chinese Han population |
| Q38885740 | Psychiatric disorders biochemical pathways unraveled by human brain proteomics |
| Q36482035 | Regulatory module network of basic/helix-loop-helix transcription factors in mouse brain |
| Q48567155 | Risk variant of oligodendrocyte lineage transcription factor 2 is associated with reduced white matter integrity |
| Q38183367 | Schizophrenia: susceptibility genes and oligodendroglial and myelin related abnormalities |
| Q37069461 | Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2. |
| Q95324293 | Single-cell-resolution transcriptome map of human, chimpanzee, bonobo, and macaque brains |
| Q37389123 | Sonic hedgehog promotes generation and maintenance of human forebrain Olig2 progenitors |
| Q33282297 | The genetics of brain wiring: from molecule to mind |
| Q38210119 | The myelin membrane-associated enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase: on a highway to structure and function |
| Q33392711 | Ultraconserved elements in the Olig2 promoter |
| Q37896626 | Understanding aberrant white matter development in schizophrenia: an avenue for therapy? |
| Q30597641 | What does anisotropy measure? Insights from increased and decreased anisotropy in selective fiber tracts in schizophrenia |
| Q36169035 | White matter abnormalities and animal models examining a putative role of altered white matter in schizophrenia |
| Q36793946 | White matter in learning, cognition and psychiatric disorders |
Search more.